Gannex, announced today that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug ... Dec 14
On February 16, 2020, the clinical trial obtained approval from the ethics committee of the Ninth Hospital of Nanchang. ... Feb 27
-Advertisements-